X
40.45
+3.27%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$7.5m
FY2016FY2025
Net income
−$345.9m
FY2016FY2025
Free cash flow
−$279.9m
FY2016FY2025
Shareholders' equity
$581.8m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5m | — | — | $9.4m | $18.4m | $32.2m | $6.8m | — | $311,000 | $1.8m |
| Gross profit | $5.0m | −$2.6m | −$167.5m | $9.4m | $18.4m | $32.2m | $6.8m | −$6.0m | −$25.3m | $689,000 |
| Research and development | $300.9m | $210.4m | $167.5m | $105.8m | $75.5m | $50.5m | $38.8m | $23.6m | $25.6m | $19.8m |
| Operating income | −$373.1m | −$279.3m | −$214.1m | −$129.1m | −$79.0m | −$31.3m | −$42.8m | −$38.0m | −$32.6m | −$24.8m |
| Net income | −$345.9m | −$234.3m | −$182.4m | −$125.4m | −$78.9m | −$28.8m | −$41.6m | −$34.5m | −$30.7m | −$23.0m |
| Diluted earnings per share | -4.36 | -2.99 | -2.61 | -1.91 | -1.91 | -0.78 | -1.25 | -1.34 | -1.72 | -1.28 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $981.7m | $798.1m | $964.8m | $754.1m | $572.0m | $189.2m | $147.7m | $122.4m | $46.1m | $67.5m |
| Cash and short-term investments | $548.9m | $626.9m | $638.1m | $592.1m | $551.8m | $177.0m | $141.4m | $119.3m | $43.7m | $64.1m |
| Total liabilities | $399.9m | $43.2m | $36.9m | $32.6m | $22.0m | $17.8m | $55.7m | $19.1m | $10.2m | $3.6m |
| Debt | $1.5m | — | — | — | — | — | $15.5m | $15.0m | $6.8m | — |
| Shareholders' equity | $581.8m | $754.9m | $927.9m | $721.5m | $550.0m | $171.4m | $92.0m | $103.3m | $35.9m | $63.9m |
| Shares outstanding | 79m | 78m | 70m | 66m | 41m | 37m | 33m | 26m | 18m | 18m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$279.1m | −$181.4m | −$145.3m | −$98.4m | −$69.5m | −$48.1m | −$4.6m | −$34.7m | −$28.7m | −$19.6m |
| Capital spending | −$799,000 | −$3.1m | −$5.6m | −$2.9m | −$2.0m | −$2.6m | −$1.2m | −$507,000 | −$315,000 | −$279,000 |
| Free cash flow | −$279.9m | −$184.5m | −$150.9m | −$101.3m | −$71.6m | −$50.8m | −$5.9m | −$35.2m | −$29.0m | −$19.8m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $7.5m | $2.5m | — |
| Gross profit | — | −$587,000 | −$611,000 | −$77.1m | −$632,000 | $7.5m | $1.3m | −$669,000 |
| Operating income | −$123.2m | −$112.3m | −$109.8m | −$96.3m | −$94.2m | −$72.7m | −$77.5m | −$73.7m |
| Net income | −$110.7m | −$102.3m | −$105.3m | −$90.9m | −$84.7m | −$65.0m | −$65.7m | −$62.8m |
| Diluted earnings per share | -1.11 | -1.03 | -1.33 | -1.15 | -1.07 | -0.82 | -0.84 | -0.80 |
| Cash from operations | −$95.0m | −$88.0m | −$81.0m | −$71.0m | −$64.0m | −$61.0m | −$54.0m | −$49.0m |
| Total assets | $1.30bn | $1.39bn | $981.7m | $607.8m | $674.3m | $743.3m | $798.1m | $835.9m |
| Cash and short-term investments | $930.7m | $1.09bn | $548.9m | $462.3m | $487.5m | $549.6m | $626.9m | $654.0m |
| Debt | $1.3m | $1.6m | $1.5m | $1.5m | $1.5m | $1.4m | $1.4m | $1.4m |
| Shareholders' equity | $1.24bn | $1.34bn | $581.8m | $559.5m | $634.0m | $704.0m | $754.9m | $797.8m |
Financial ratios
Data as of 23 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 66.1% | — | — | 100.0% | 100.0% | 100.0% | 100.0% | — | -8122.8% | — | — | — |
| Operating margin | -4598.6% | — | — | -1368.9% | -428.4% | -97.3% | -588.4% | — | -9872.7% | — | — | — |
| Net margin | -4612.1% | — | — | -1328.9% | -427.8% | -89.7% | -609.1% | — | -9872.7% | — | — | — |
| Return on equity | -59.5% | -31.0% | -19.7% | -17.4% | -14.3% | -16.8% | — | — | — | — | — | — |
| Return on assets | -35.2% | -29.4% | -18.9% | -16.6% | -13.8% | -15.2% | — | — | — | — | — | — |
| Free cash flow yield | -9.6% | -6.2% | -5.5% | -4.0% | -4.5% | -3.4% | — | — | — | — | — | — |
| Revenue growth | — | — | — | -48.8% | -42.7% | 371.0% | — | — | -82.8% | -88.4% | -45.1% | — |
| Earnings growth | 47.6% | 28.5% | 45.5% | 58.9% | 173.5% | -30.7% | — | — | — | — | — | — |
| Current ratio | 13.42x | 17.85x | 23.65x | 26.44x | 39.03x | 12.30x | — | — | — | — | — | — |
| Debt to equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | — | — | — | — | — | — |
| Equity ratio | 59.3% | 94.6% | 96.2% | 95.7% | 96.2% | 90.6% | — | — | — | — | — | — |
| Interest coverage | — | — | — | -23.43x | -78.13x | -64.67x | -28.02x | -23.76x | — | — | — | 151.75x |
| R&D as a share of sales | 4012.5% | — | — | 1121.1% | 409.3% | 157.1% | 568.8% | — | 8222.8% | — | — | — |
| Buybacks as a share of market value | -1.1% | -12.0% | -6.6% | -59.4% | -11.9% | -11.0% | — | — | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -7.4% | -25.3% | -7.0% |
| Operating income | 42.4% | 64.2% | 44.6% |
| Net income | 40.3% | 64.4% | 36.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -10.3 | -13.1 | -17.7 | -20.6 | -16.3 | -19.6 | -10.5 | -4.7 | -1.6 | -2.8 |
| Price to sales | 473.6 | — | — | 274.4 | 69.8 | 17.6 | 63.7 | — | 161.7 | 36.2 |
Market value over time
30 Nov 2016 to 22 Oct 2026, in USD
$119.1m$3.64bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 10% | -6% | 10% | 33% | 101% | 6% | 132% | 133% | -35% | 2% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.